A-V conduction disturbance: its pathophysiology and pharmacology.
D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology; D001552:Benzazepines / Q000494:pharmacology; D002301:Cardiac Glycosides / Q000494:pharmacology; D006329:Heart Conduction System / Q000187:drug effects / Q000503:physiopathology*; D007093:Imidazoles / Q000494:pharmacology; D008274:Magnesium / Q000494:pharmacology; D010672:Phenytoin / Q000494:pharmacology; D011188:Potassium / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011802:Quinidine / Q000494:pharmacology; D011817:Rabbits; D012964:Sodium / Q000494:pharmacology; D013779:Tetrodotoxin / Q000494:pharmacology
D000889:Anti-Arrhythmia Agents; D001552:Benzazepines; D002301:Cardiac Glycosides; D007093:Imidazoles; D013779:Tetrodotoxin; D010672:Phenytoin; D012964:Sodium; D011433:Propranolol; D008274:Magnesium; D011802:Quinidine; D011188:Potassium